Manulife (Manufacturers Life Insurance)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,634
Closed -$1.93M 2907
2025
Q2
$1.93M Sell
19,634
-1,066
-5% -$101K ﹤0.01% 1512
2025
Q1
$1.92M Sell
20,700
-545
-3% -$50.2K ﹤0.01% 1498
2024
Q4
$1.93M Sell
21,245
-354
-2% -$32.5K ﹤0.01% 1577
2024
Q3
$2.08M Sell
21,599
-1,038
-5% -$101K ﹤0.01% 1533
2024
Q2
$2.08M Sell
22,637
-685
-3% -$63.6K ﹤0.01% 1484
2024
Q1
$2.15M Buy
23,322
+1,044
+5% +$97.8K ﹤0.01% 1493
2023
Q4
$2.12M Sell
22,278
-827
-4% -$77.2K ﹤0.01% 1456
2023
Q3
$2.16M Sell
23,105
-1,210
-5% -$112K ﹤0.01% 1414
2023
Q2
$2.22M Sell
24,315
-822
-3% -$67.4K ﹤0.01% 1387
2023
Q1
$1.85M Sell
25,137
-1,132
-4% -$97.9K ﹤0.01% 1424
2022
Q4
$2.19M Sell
26,269
-80
-0.3% -$7.21K ﹤0.01% 1359
2022
Q3
$2.55M Sell
26,349
-968
-4% -$115K ﹤0.01% 1319
2022
Q2
$2.87M Sell
27,317
-237
-0.9% -$30.3K ﹤0.01% 1335
2022
Q1
$4.75M Sell
27,554
-9,257
-25% -$1.38M ﹤0.01% 1212
2021
Q4
$5.96K Sell
36,811
-784
-2% -$126K ﹤0.01% 1177
2021
Q3
$5.61M Buy
37,595
+1,912
+5% +$397K ﹤0.01% 1194
2021
Q2
$8.74M Sell
35,683
-1,183
-3% -$310K 0.01% 1019
2021
Q1
$9.76M Sell
36,866
-2,626
-7% -$741K 0.01% 968
2020
Q4
$11.6M Sell
39,492
-3,072
-7% -$788K 0.01% 829
2020
Q3
$10.1M Sell
42,564
-850
-2% -$193K 0.01% 798
2020
Q2
$8.57M Sell
43,414
-21,775
-33% -$4.06M 0.01% 844
2020
Q1
$12M Buy
65,189
+2,019
+3% +$359K 0.01% 658
2019
Q4
$10.5M Sell
63,170
-2,989
-5% -$445K 0.01% 804
2019
Q3
$8.54M Buy
66,159
+29
+0% +$3.77K 0.01% 908
2019
Q2
$8.03M Buy
66,130
+1,826
+3% +$217K 0.01% 958
2019
Q1
$7.93M Buy
64,304
+46,089
+253% +$5.78M 0.01% 994
2018
Q4
$2.13M Buy
18,215
+10,508
+136% +$1.24M ﹤0.01% 1368
2018
Q3
$963K Sell
7,707
-13,430
-64% -$1.48M ﹤0.01% 1827
2018
Q2
$1.8M Sell
21,137
-127
-0.6% -$9.33K ﹤0.01% 1534
2018
Q1
$1.28M Sell
21,264
-635
-3% -$36.2K ﹤0.01% 1698
2017
Q4
$1.15M Sell
21,899
-42
-0.2% -$2.21K ﹤0.01% 1766
2017
Q3
$1.23M Sell
21,941
-407
-2% -$21.5K ﹤0.01% 1667
2017
Q2
$1.4M Buy
22,348
+410
+2% +$23.9K ﹤0.01% 1605
2017
Q1
$1.12M Buy
21,938
+2,604
+13% +$124K ﹤0.01% 1679
2016
Q4
$824K Buy
19,334
+148
+0.8% +$6.29K ﹤0.01% 1770
2016
Q3
$910K Buy
19,186
+176
+0.9% +$8.78K ﹤0.01% 1699
2016
Q2
$960K Buy
19,010
+303
+2% +$15.3K ﹤0.01% 1644
2016
Q1
$892K Buy
18,707
+174
+0.9% +$6.71K ﹤0.01% 1672
2015
Q4
$729 Buy
18,533
+183
+1% +$7.32K ﹤0.01% 1790
2015
Q3
$696 Buy
18,350
+418
+2% +$17.6K ﹤0.01% 1790
2015
Q2
$713 Sell
17,932
-180
-1% -$5.61K ﹤0.01% 1880
2015
Q1
$485 Buy
18,112
+669
+4% +$18.9K ﹤0.01% 2095
2014
Q4
$512 Sell
17,443
-493
-3% -$12.2K ﹤0.01% 1960
2014
Q3
$361 Sell
17,936
-104
-0.6% -$2.01K ﹤0.01% 2212
2014
Q2
$302K Sell
18,040
-6,371
-26% -$90.3K ﹤0.01% 2410
2014
Q1
$363 Buy
24,411
+361
+2% +$5.56K ﹤0.01% 2292
2013
Q4
$352 Buy
24,050
+358
+2% +$5.76K ﹤0.01% 2301
2013
Q3
$408 Buy
23,692
+277
+1% +$4.11K ﹤0.01% 2117
2013
Q2
$272K Buy
+23,415
New +$268K ﹤0.01% 2324

Other funds holding AMED

Manulife (Manufacturers Life Insurance)'s AMED Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 19,634 shares — an estimated $1.93M sold.

Manulife (Manufacturers Life Insurance) first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $12M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 19,634 Amedisys shares in Q3 2025, an estimated $1.93M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Manulife (Manufacturers Life Insurance)'s Amedisys position peaked at $12M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.